Witryna28 maj 2008 · The ImmuKnow assay measures cell-mediated immunity and is able to discern between conditions of overimmunosuppression and underimmunosuppression. The aim of this study was to evaluate the ImmuKnow assay in the evaluation of the immune function in pediatric liver transplant recipients and to assess its correlation … WitrynaImmuKnow 176120 For additional information, including specimen requirements, CPT coding, and RUO/IUO status, consult the online Test Menu at www.labcorp.com. …
Individualized immune monitoring of cardiac transplant recipients …
WitrynaBackground and objectives: Current assays and tests that are used to determine the degree of immunosuppression in renal transplant recipients are suboptimal. The ImmuKnow assay (Cylex), a measure of intracellular CD4+ T cell ATP release proposed as a means to quantify cell-mediated immunity in transplant recipients, could be … Witryna27 kwi 2010 · Background: Common immunosuppression strategies after heart transplantation (HTx) are based on accepted target drug levels, disregarding that drug levels do not correlate with the individual patient's pharmacokinetics or with the actual immunosuppressive drug effect on the patient. The Immuknow assay is used for … crystal photographs
心脏移植在美国获得进展--《国外医学情报》1980年04期
WitrynaImmuKnow-Cylex ()检测与T细胞形态学变化的临床应用. 目的:探讨同种异体原位肝移植 (OLT)病人围手术期外周静脉血ImmuKnow免疫细胞功能检测值,T淋巴细胞形态学变 … WitrynaImmuKnow ® is the only FDA-cleared, reimbursable assay designed to detect changes in immune cell function over time, giving you crucial insight for individualized patient management. By identifying changes in CD4 cell ATP production 1,2, the ImmuKnow ® assay helps define a range of stable immune function for solid organ transplant … WitrynaThis test is a transplant physician's means of obtaining and monitoring information about immune status. ImmuKnow® measures the adenosine triphosphate (ATP) response of stimulated peripheral blood lymphocytes. crystal photos near me